Two River, Merck alum Snyder joins Generate as CMO
Plus Nagorse becomes CMO at Affini-T and updates from Apollomics, Circle and more
Generate Biomedicines Inc. hired Alexandra Snyder as CMO. Snyder was a principal at Two River, where she was responsible for the translational and clinical strategy of the private equity firm’s portfolio of biotech companies. Before that, she was the head of translational oncology at Merck & Co. Inc. (NYSE:MRK). Generate announced the hiring of CFO Jason Silvers on Monday. The Flagship Pioneering portfolio company raised a $370 million series B for its machine learning-based protein design platform in November.
Fred Hutch spinout Affini-T Therapeutics Inc. hired Dirk Nagorsen as CMO. Nagorsen was VP early development and therapeutic area head, hematology & oncology early development at Amgen Inc. (NASDAQ:AMGN), where he oversaw programs including Lumakras sotorasib and T cell-based agents. Affini-T is targeting oncogenic and viral driver mutations with CD4+ and CD8+ T cells engineered to express TCRs and synthetic biology switches that enhance proliferation, persistence and killing activity. The company is led by Leaps by Bayer veteran Jak Knowles, who is co-founder, president and CEO...